IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-28 AccNo: 0001104659-16-107919 Size: 265 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-03-23 AccNo: 0001493152-16-008213 Size: 106 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-23 AccNo: 0001493152-16-008212 Size: 6 MB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2016-03-23 16:30 After Market Close:IMPRIMIS PHARMA Earning Release 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-21 AccNo: 0000905718-16-001269 Size: 40 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-03-14 AccNo: 0001493152-16-008014 Size: 645 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-03-14 AccNo: 0001493152-16-008012 Size: 492 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-03-11,10% Owner,Opaleye Management Inc. ,买入,45000普通股, $3.65
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-03-11 AccNo: 0001493152-16-008006 Size: 299 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-03-10 AccNo: 0001493152-16-007944 Size: 653 KB 网页链接